Source:http://linkedlifedata.com/resource/pubmed/id/16406651
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2006-3-17
|
pubmed:abstractText |
Endometrial periglandular fibrosis (EPF) contributes to embryonic and fetal loss in mares. Equine EPF correlates inversely with conception and successful gestation. In the modified Kenney endometrial biopsy classification system, EPF categories I, IIA, IIB, and III correspond to minimal, mild, moderate, and severe fibrosis (+/-inflammation), respectively. Paraffin sections of biopsy specimens were stained with H&E, and picrosirius red (specific for fibrillar collagens types I and III), to determine %EPCVF. Endometrial ACE-binding activity, TGF-beta1 and 11beta-HSD2 activities were also measured. Ultrastructural changes in EPF categories IIB and III endometria strongly suggested myofibroblastic transformation. ACE-binding activity was highest in EPF category IIB; however, endometrial TGF-beta1 and 11beta-HSD2 activities were significantly correlated to the severity of EPF (P<0.05). We conclude that, locally generated angiotensin II initiates the expression of TGF-beta1 resulting in myofibroblastic transformation. 11Beta-HSD2 in concert appears to modulate the severity of endometrial fibrosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/11-beta-Hydroxysteroid...,
http://linkedlifedata.com/resource/pubmed/chemical/Peptidyl-Dipeptidase A,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0303-7207
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
248
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
104-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16406651-11-beta-Hydroxysteroid Dehydrogenase Type 2,
pubmed-meshheading:16406651-Animals,
pubmed-meshheading:16406651-Endometrium,
pubmed-meshheading:16406651-Female,
pubmed-meshheading:16406651-Fibrosis,
pubmed-meshheading:16406651-Horse Diseases,
pubmed-meshheading:16406651-Horses,
pubmed-meshheading:16406651-Peptidyl-Dipeptidase A,
pubmed-meshheading:16406651-Transforming Growth Factor beta,
pubmed-meshheading:16406651-Transforming Growth Factor beta1,
pubmed-meshheading:16406651-Uterine Diseases
|
pubmed:year |
2006
|
pubmed:articleTitle |
Equine endometrial fibrosis correlates with 11beta-HSD2, TGF-beta1 and ACE activities.
|
pubmed:affiliation |
Biomedical Sciences, W118 College of Veterinary Medicine, University of Missouri-Columbia, Columbia, MO 65211-0001, USA. ganjamv@missouri.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|